Recombinant and native TviCATL from Trypanosoma vivax: enzymatic characterisation and evaluation as a diagnostic target for animal African trypanosomosis

Lauren E-A Eyssen, Perina Vather, Laurelle Jackson, Phindile Ximba, Nicolas Biteau, Théo Baltz, Alain Boulangé, Philippe Büscher, Theresa H T Coetzer

    Research output: Contribution to journalA1: Web of Science-article


    African animal trypanosomosis (nagana) is caused by tsetse-transmitted protozoan parasites. Their cysteine proteases are potential chemotherapeutic and diagnostic targets. The N-glycosylated catalytic domain of Trypanosoma vivax cathepsin L-like cysteine protease, rTviCATLcat, was recombinantly expressed and purified from culture supernatants while native TviCATL was purified from T. vivax Y486 parasite lysates. Typical of Clan CA, family C1 proteases, TviCATL activity is sensitive to E-64 and cystatin and substrate specificity is defined by the S2 pocket. Leucine was preferred in P2 and basic and non-bulky, hydrophobic residues accepted in P1 and P3 respectively. Reversible aldehyde inhibitors, antipain, chymostatin and leupeptin, with Arg in P1 and irreversible peptidyl chloromethylketone inhibitors with hydrophobic residues in P2 inhibited TviCATL activity. TviCATL digested host proteins: bovine haemoglobin, serum albumin, fibrinogen and denatured collagen (gelatine) over a wide pH range, including neutral to slightly acidic pH. The recombinant catalytic domain of TviCATL showed promise as a diagnostic target for detecting T. vivax infection in cattle in an indirect antibody detection ELISA.

    Original languageEnglish
    JournalMolecular and Biochemical Parasitology
    Pages (from-to)50-54
    Number of pages5
    Publication statusPublished - 2018


    Dive into the research topics of 'Recombinant and native TviCATL from <em>Trypanosoma vivax</em>: enzymatic characterisation and evaluation as a diagnostic target for animal African trypanosomosis'. Together they form a unique fingerprint.

    Cite this